S. Marso Et Al. , "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.," The New England journal of medicine , vol.375, pp.311-22, 2016
Marso, S. Et Al. 2016. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.. The New England journal of medicine , vol.375 , 311-22.
Marso, S., Daniels, G., Brown-Frandsen, K., Kristensen, P., Mann, J., Nauck, M., ... Nissen, S.(2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.. The New England journal of medicine , vol.375, 311-22.
Marso, SP Et Al. "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.," The New England journal of medicine , vol.375, 311-22, 2016
Marso, SP Et Al. "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.." The New England journal of medicine , vol.375, pp.311-22, 2016
Marso, S. Et Al. (2016) . "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.." The New England journal of medicine , vol.375, pp.311-22.
@article{article, author={SP Marso Et Al. }, title={Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.}, journal={The New England journal of medicine}, year=2016, pages={311-22} }